Tags

Type your tag names separated by a space and hit enter

Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate.
Am J Clin Nutr. 2000 Jun; 71(6):1597-602.AJ

Abstract

BACKGROUND

Infant cereals are commonly fortified with insoluble iron compounds with low relative bioavailability, such as ferric pyrophosphate, because of organoleptic changes that occur after addition of water-soluble iron sources.

OBJECTIVE

Our objective was to compare iron bioavailability from ferric pyrophosphate with an alternative iron source that is soluble in dilute acid, ferrous fumarate, and to evaluate the influence of ascorbic acid on iron bioavailability from ferrous fumarate in infants.

DESIGN

Iron bioavailability was measured as the incorporation of stable iron isotopes into erythrocytes 14 d after administration of labeled test meals (25 g dry wheat and soy infant cereal, 100 g water, and 2.5 mg Fe as [57Fe]ferric pyrophosphate or [57Fe]ferrous fumarate). Ascorbic acid was added to all test meals (25 mg in study 1 or 25 or 50 mg in study 2). Infants were fed each test meal on 4 consecutive days under standardized conditions. The 2 different test meals within each study were administered 2 wk apart in a crossover design.

RESULTS

Geometric mean iron bioavailability was significantly higher from [57Fe]ferrous fumarate than from [57Fe]ferric pyrophosphate [4.1% (range: 1.7-14.7%) compared with 1.3% (range: 0. 7-2.7%); n = 8, P = 0.008]. In this study, doubling the ascorbic acid content did not further enhance iron bioavailability; the geometric means (range) were 3.4% (1.9-6.6%) and 4.2% (1.2-18.7%) for the test meals with 25 and 50 mg ascorbic acid added, respectively (n = 9).

CONCLUSION

Iron bioavailability from iron-fortified infant cereals can be improved by using an iron compound with high relative bioavailability and by ensuring adequate ascorbic acid content of the product.

Authors+Show Affiliations

Laboratory for Human Nutrition, Institute of Food Science, Swiss Federal Institute of Technology, R]uschlikon, Switzerland. davidsson@ilw.agrl.ethz.chNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

10837304

Citation

Davidsson, L, et al. "Iron Bioavailability in Infants From an Infant Cereal Fortified With Ferric Pyrophosphate or Ferrous Fumarate." The American Journal of Clinical Nutrition, vol. 71, no. 6, 2000, pp. 1597-602.
Davidsson L, Kastenmayer P, Szajewska H, et al. Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate. Am J Clin Nutr. 2000;71(6):1597-602.
Davidsson, L., Kastenmayer, P., Szajewska, H., Hurrell, R. F., & Barclay, D. (2000). Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate. The American Journal of Clinical Nutrition, 71(6), 1597-602.
Davidsson L, et al. Iron Bioavailability in Infants From an Infant Cereal Fortified With Ferric Pyrophosphate or Ferrous Fumarate. Am J Clin Nutr. 2000;71(6):1597-602. PubMed PMID: 10837304.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate. AU - Davidsson,L, AU - Kastenmayer,P, AU - Szajewska,H, AU - Hurrell,R F, AU - Barclay,D, PY - 2000/6/6/pubmed PY - 2000/7/25/medline PY - 2000/6/6/entrez SP - 1597 EP - 602 JF - The American journal of clinical nutrition JO - Am J Clin Nutr VL - 71 IS - 6 N2 - BACKGROUND: Infant cereals are commonly fortified with insoluble iron compounds with low relative bioavailability, such as ferric pyrophosphate, because of organoleptic changes that occur after addition of water-soluble iron sources. OBJECTIVE: Our objective was to compare iron bioavailability from ferric pyrophosphate with an alternative iron source that is soluble in dilute acid, ferrous fumarate, and to evaluate the influence of ascorbic acid on iron bioavailability from ferrous fumarate in infants. DESIGN: Iron bioavailability was measured as the incorporation of stable iron isotopes into erythrocytes 14 d after administration of labeled test meals (25 g dry wheat and soy infant cereal, 100 g water, and 2.5 mg Fe as [57Fe]ferric pyrophosphate or [57Fe]ferrous fumarate). Ascorbic acid was added to all test meals (25 mg in study 1 or 25 or 50 mg in study 2). Infants were fed each test meal on 4 consecutive days under standardized conditions. The 2 different test meals within each study were administered 2 wk apart in a crossover design. RESULTS: Geometric mean iron bioavailability was significantly higher from [57Fe]ferrous fumarate than from [57Fe]ferric pyrophosphate [4.1% (range: 1.7-14.7%) compared with 1.3% (range: 0. 7-2.7%); n = 8, P = 0.008]. In this study, doubling the ascorbic acid content did not further enhance iron bioavailability; the geometric means (range) were 3.4% (1.9-6.6%) and 4.2% (1.2-18.7%) for the test meals with 25 and 50 mg ascorbic acid added, respectively (n = 9). CONCLUSION: Iron bioavailability from iron-fortified infant cereals can be improved by using an iron compound with high relative bioavailability and by ensuring adequate ascorbic acid content of the product. SN - 0002-9165 UR - https://www.unboundmedicine.com/medline/citation/10837304/Iron_bioavailability_in_infants_from_an_infant_cereal_fortified_with_ferric_pyrophosphate_or_ferrous_fumarate_ L2 - https://academic.oup.com/ajcn/article-lookup/doi/10.1093/ajcn/71.6.1597 DB - PRIME DP - Unbound Medicine ER -